Polymyalgia Rheumatica-Like Syndrome from Checkpoint Inhibitor Therapy
Is checkpoint inhibitor-related polymyalgia rheumatica distinct from the classic rheumatic disease?
Related Articles
Teamwork and Quick Action Help 4-Year-Old with Mysterious Nasal Symptoms
When a pediatric patient presented with severe congestion, snoring and a progressive cough, X-ray findings revealed the surprising source of the patient’s symptoms.
Imaging Options Compared for Septal and Mitral Measurement in Myectomy for HOCM
New prospective data could shape how multimodality imaging is used in surgical planning for patients with hypertrophic obstructive cardiomyopathy. New research on optimal imaging modalities…
CSF Alpha-Synuclein Biomarker Strongly Associated With Clinical Features of Dementia With Lewy Bodies
A positive result on an alpha-synuclein assay is highly associated with clinical features of dementia with Lewy bodies, especially a reduced sense of smell. Multicenter…
Co-Testing in the ED to Slow the Spread of HIV
Patients being seen in the ED for common sexually transmitted infections should be screened for HIV, too.
New Targeted Therapy for GE Cancer
A newly approved targeted therapy, zolbetuximab, improves outcomes for patients whose tumor express the protein CLDN18.2.
Study Suggests Non-Biopsy Diagnosis May Be Accurate for a Select Group of Adults with Celiac Disease
New findings suggest a non-biopsy diagnosis of celiac disease may be accurate in a small subset of U.S. adults.
Allograft Renal Cell Carcinoma From the Donor: Rare, but Possible
Important takeaways from a rare complication
The Cleveland Clinic Brain Study at 3 Years: Initial Insights, Surprises and Next Steps
Three years into the Cleveland Clinic Brain Study, we share early findings, surprises and what’s next for this unprecedented longitudinal study in a population without…
Surgical Treatment for 4 Types of Wrist Fractures
Treatment for wrist fractures depends on the nature and severity of injury. A hand and wrist surgeon explains the variations.
Pharmacokinetics of Many Anticancer Drugs Differ Among Sexes
A team of researchers recently found notable pharmacokinetic (PK) differences between males and females in at least 14 anticancer drugs.